This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The way physicians identify illness is changing due to advances in medical imaging, which make early diagnosis quicker, more precise, and less invasive. These technologies, ranging from high-resolution MRIs to state-of-the-art CT scans, can give doctors the ability to spot possible health problems before symptoms even show up.
F-18 fluoroestradiol (FES)-PETscans can predict whether or not endocrine therapy may be effective in women with estrogen receptor (ER)-positive breast cancer, according to a study published March 13 in the Journal of Nuclear Medicine. Image courtesy of the Journal of Nuclear Medicine. A visual abstract of the analysis.
Preliminary studies suggest the tracer may also be effective in patients with earlier, more treatable stages of the disease, yet most of these studies have been retrospective and subject to a large risk of bias, the authors noted. The tumor in the right breast (T4N0M0, grade 3 ductal carcinoma) is visible on both PETscans.
CHICAGO -- Characterizing an individual's type of body fat using body MRI can help predict Alzheimer's disease risk up to 20 years before symptoms manifest, according to research results presented December 2 at the RSNA meeting. Images courtesy of the RSNA.
Alzheimer’s disease patients with cognitive impairment or dementia who were referred for amyloid PETscans had fewer hospitalizations compared with a matched control group, according to a study published October 9 in JAMA Neurology. Each participant was matched to a control Medicare beneficiary who had not undergone amyloid PET.
Men should have prostate-specific membrane antigen (PSMA) PETscans about eight months after undergoing external beam radiotherapy for prostate cancer, a group at the University of California, Los Angeles has reported. The median duration between the first PETscan and the end-date of radiotherapy was 2.3
National Institutes of Health (NIH) has highlighted a study that shows cardiac PETscans can help identify people at risk for Parkinson’s disease and Lewy body dementia. Significantly, the research supports a “body first” progression model for the diseases, the researchers suggested. “We
TORONTO -- AuntMinnie.com spoke with prostate cancer imaging expert Phillip Kuo, MD, PhD, of the City of Hope in Duarte, CA, at the Society of Nuclear Medicine and Molecular Imaging annual meeting about new developments in PET/CT imaging in patients on Lu-177 PSMA-617 therapy. last year for Alzheimer's disease.
F-18 florbetaben PETscans for diagnosing Alzheimer’s disease can be reduced from 20 minutes to five minutes without losing accuracy, according to a recent study. Our findings suggest that shorter scan times are a viable and effective option for brain amyloid PETimaging in clinical settings,” the group wrote.
In a recent PET study with unexpected results, patients infected with herpes had fewer signs of brain deposits associated with Alzheimers disease than uninfected patients, a group in France has reported. The study was published January 18 in Scientific Reports. The median age of the group was 74 years old.
PETscans have revealed specific brain pathology that may drive sleep disturbances in Alzheimer’s disease patients, according to a study published February 8 in the Journal of the Neurological Sciences. Of these, 119 (43%) had normal cognition, 132 (24%) had mild cognitive impairment, and three (2%) had Alzheimer’s disease.
Food and Drug Administration (FDA) has approved Eli Lilly's drug donanemab (Kisunla) for the treatment of early Alzheimer's disease, including mild cognitive impairment or mild dementia. According to clinical trials, amyloid PETscans showed that donanemab reduced amyloid plaques by up to 84% after 18 months of treatment.
PETimaging with nitrogen-13 (N-13) ammonia radiotracer can help predict major adverse cardiac events in patients with ischemic heart disease (IHD), according to a study published May 30 in Radiology: Cardiothoracic Imaging. Patients underwent the scans between January 2017 and January 2021.
PETimaging using a newly developed radiotracer has identified different patterns of brain tau pathology over time in early-onset versus late-onset Alzheimer’s disease patients, according to a study published February 1 in the Journal of Nuclear Medicine. in 15 patients with negative amyloid PETscans; 1.18 in
PET brain scans show persistent brain inflammation in patients with multiple sclerosis (MS), despite being treated with high-efficacy disease-modifying therapies, according to a recent study by researchers in Boston. The researchers performed F-18 PBR06 PETscans on 22 patients with MS and eight healthy controls.
A PET study has revealed that women over the age of 70 who took menopausal hormone therapy (HT) more than a decade before have faster brain tau accumulation -- a key indicator of Alzheimers disease. The findings may inform [Alzheimers disease] risk discussions relating to womens reproductive health and treatment, the group wrote.
Centers for Medicare and Medicaid Services (CMS) announced on October 13 that it has lifted its coverage limit of one beta-amyloid PETscan per lifetime for patients with Alzheimer’s disease. Medicare coverage decisions for amyloid PETscans will now be made by local Medicare Administrative Contractors (MACs).
A group in France has offered an explanation for long COVID brain fog, with the concept based on a visual brain pattern they discovered on patient PETscans, according to a study published October 13 in Medical Hypotheses. “We A) PETscan of a healthy subject. (B) B) PETscan of a long COVID patient.
Centers for Medicare and Medicaid Services (CMS) proposed a new reimbursement plan July 10 for diagnostic PETscans that would provide separate payments for radiopharmaceuticals, as well as an extra payment for hospitals when they use domestically produced technetium-99m (Tc-99m).
An AI algorithm designed for brain PETimaging found a glioblastoma in a patient that had gone undetected by physicians, according to a case reported February 15 in the Journal of Nuclear Medicine. Baseline scan (A), segmentation results (B), and follow-up scan (C) from patient with molecular glioblastoma.
Early brain accumulation of amyloid plaque on PETscans is associated with emerging depressive symptoms in cognitively unimpaired older adults, according to a study published August 29 in JAMA Network Open. Their aim in this study was to determine whether these associations persist or progress over time.
A group led by researchers at the University of Arizona has received a $4 million grant from the National Institutes of Health (NIH) to develop multitracer brain PETimaging technology. The group’s technology aims to overcome this limitation by taking advantage of prompt gamma signals in addition to the positron signals.
Chinese clinicians have provided evidence in a “real-world study” that shows amyloid PETimaging is effective for diagnosing and managing patients with Alzheimer’s disease, according to a study published February 8 in Alzheimer’s and Dementia. in 2012. “The
A deep-learning AI model shows promise in helping clinicians assess cardiac sarcoidosis on PETscans, according to research presented on September 6 at the American Society of Nuclear Cardiology annual meeting in Austin, TX. In the absence of treatment, the disease can lead to irreversible fibrosis and sudden cardiac death.
A PET radiotracer for diagnosing Alzheimer’s disease may also be used to measure vascular brain changes in patients during PET/MRI scans, according to a study published December 7 in the Journal of Nuclear Medicine. Image courtesy of the Journal of Nuclear Medicine. A link to the full study is available here.
Food and Drug Administration (FDA) approval for its flurpiridaz F-18 radiotracer for PETimaging of coronary artery disease. Although PET MPI as a modality enables high diagnostic accuracy as compared with SPECT MPI, only a minority of annual PETscans in the U.S. with 695,000 deaths recorded in 20214.
A PET/MRI study has provided insights into the neurobiology of late-life depression, with researchers reporting that tau protein – a key protein involved in Alzheimer’s disease – does not appear to be involved in the condition. Image and caption courtesy of the American Journal of Geriatric Psychiatry.
A group in England has established PETimaging as a new approach for studying gait – an excellent indicator of physical, emotional, and mental health, according to a study published February 6 in NeuroImage. F-18 FDG-PETscans allow clinicians to measure the brain's energy demands based on glucose metabolism.
PETscans typically used for diagnosing prostate cancer may have value in detecting inflammatory bowel disease (IBD), according to a case series published December 8 in Clinical and Experimental Gastroenterology. A) F-18 DCFPyL PET/CT uptake in the descending colon on a coronal plane. (B)
Radiotracers are radioactive compounds which give off radiation that can be detected by scanners and turned into a 3D image. The new radiotracer, called FDT, enables PETscans to be used for the first time to accurately pinpoint when and where the disease is still active in a patient's lungs.
People with higher amounts of visceral abdominal fat in midlife may be at increased risk of Alzheimer's disease, according to research to be presented at the upcoming RSNA meeting. Image courtesy of the RSNA. The ubiquity of the condition makes early detection crucial. The green colors are the normal white matter.
PET/CT imaging with a new radiotracer (F-18 PSMA-1007) is superior to MRI prior to surgery in men with intermediate-risk and high-risk prostate cancer, according to a study published on July 1 in JAMA Oncology. Out of 150 men who participated, 134 ultimately underwent radical prostatectomies (the mean age was 62 years old).
FDG-PETimaging shows promise for use as a diagnostic criterion for neurosarcoidosis, with a recent case series illustrating the approach was effective when gold-standard approaches were not, according to a group of researchers in Berlin. “To In all three cases, gadolinium-enhanced MRI scans did not show abnormalities.
Researchers in Germany have proposed a new approach derived from brain PETimaging for diagnosing and staging Alzheimers disease, according to a study published March 25 in Radiology. Image and caption courtesy of RSNA. Schematic illustrates how fill states are derived. (A) A) Derivation of an exemplary tau fill state.
more than 6 million Americans have Alzheimer's disease, a debilitating and far-reaching disease that accounts for 60% to 80% of dementia cases, and by 2050, this number is projected to rise to nearly 13 million, according to Alzheimer’s Disease International. The disease affects memory, thinking, and behavior. In the U.S.,
PETimaging has revealed brain pathology linked to faster clinical progression of Alzheimer’s disease in patients with ApoE4 gene variants, according to a study published November 6 in JAMA Neurology.
The team has worked for the past eight years on developing an approach of imaging cells called microglia. Microglia are immune cells in the brain that are thought to have a role in MS disease progression but cannot be seen by a routine MRI. The team developed a technique called F18 PBR 06 PETimaging.
The following is the list of candidates for the 2024 edition of the Minnies, AuntMinnie.com 's campaign to recognize the best and brightest in medical imaging. Image from Martin W. tesla brain MRI scans. Image from Denis Le Bihan, PhD, of the NeuroSpin research facility, et al. AI detects cancer on breast MRI.
FAPI-PETimaging could emerge as a new tool for assessing patients with single pulmonary tumors, especially in those with negative results on other scans, according to a study published April 11 in the Journal of Nuclear Medicine. FAPI-PET either confirmed or ruled out the disease in all cases, the group found.
Read more on AuntMinnie.com Related Reading: NaF-PET shows bone formation in psoriatic arthritis patients PET/MRI provides new insights into knee osteoarthritis NaF-PET reveals aortic wall injuries NaF-PETscans reveal plaque -- and possible risk of stroke Can deep learning monitor lesions on F-18 NaF PET/CT?
TRA Medical Imaging is proud to offer PSMA PET, a cutting-edge imaging method that enables us to detect prostate cancer with greater precision than conventional imaging techniques. Race: African American men have a higher incidence of prostate cancer and are more likely to develop aggressive forms of the disease.
PET has revealed that mechanisms other than amyloid brain deposits may underlie depressive symptoms in people later in life, according to a recent study. The group determined the presence or absence of amyloid pathology in the groups based on amyloid PETscans, as well as beta-amyloid 1-42 levels in cerebrospinal fluid.
The Medical Imaging and Technology Alliance (MITA) has raised concerns ove. Read more on AuntMinnie.com Related Reading: ACR urges full coverage for amyloid PETscans CMS proposal covers PETscans for Alzheimer’s disease MITA praises FDA for Leqembi approval FIND Act reintroduced in U.S.
We organize all of the trending information in your field so you don't have to. Join 5,000 users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content